Fragmented central venous catheter retained for years with minimal symptoms

por Mullan, Clancy W., Tariq, Umair, Goldin, Mark
Publicado 2017

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors

por Spyropoulos, Alex C., Giannis, Dimitrios, Goldin, Mark
Publicado 2021

Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review

por Gianni, Panagiota, Goldin, Mark, Ngu, Sam, Zafeiropoulos, Stefanos, Geropoulos, Georgios, Giannis, Dimitrios
Publicado 2022

Impact of recent guideline changes on aspirin prescribing after knee arthroplasty

por Shah, Sarav S., Satin, Alexander M., Mullen, James R., Merwin, Sara, Goldin, Mark, Sgaglione, Nicholas A.
Publicado 2016

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial

por Piazza, Gregory, Spyropoulos, Alex C., Hsia, Judith, Goldin, Mark, Towner, William J., Go, Alan S., Bull, Todd M., Weng, Stephen, Lipardi, Concetta, Barnathan, Elliot S., Bonaca, Marc P.
Publicado 2023

Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19

por Giannis, Dimitrios, Barish, Matthew A., Goldin, Mark, Cohen, Stuart L., Kohn, Nina, Gianos, Eugenia, Chatterjee, Saurav, Lesser, Martin, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Spyropoulos, Alex C.
Publicado 2021

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

por Spyropoulos, Alex C., Cohen, Stuart L., Gianos, Eugenia, Kohn, Nina, Giannis, Dimitrios, Chatterjee, Saurav, Goldin, Mark, Lesser, Marty, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Barish, Matthew A.
Publicado 2021

External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19

por Goldin, Mark, Lin, Stephanie K., Kohn, Nina, Qiu, Michael, Cohen, Stuart L., Barish, Matthew A., Gianos, Eugenia, Diaz, Anise, Richardson, Safiya, Giannis, Dimitrios, Chatterjee, Saurav, Coppa, Kevin, Hirsch, Jamie S., Ngu, Sam, Firoozan, Sheila, McGinn, Thomas, Spyropoulos, Alex C.
Publicado 2021

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

por Spyropoulos, Alex C., Goldin, Mark, Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Hiatt, William R., Halperin, Jonathan L., Maynard, Gregory, Steg, P. Gabriel, Weitz, Jeffrey I., Spiro, Theodore E., Lu, Wentao, Marsigliano, Jessica, Raskob, Gary E., Barnathan, Elliot S.
Publicado 2022

Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older

por Ageno, Walter, Lopes, Renato D., Goldin, Mark, Yusen, Roger D., Albers, Gregory W., Elliott, Gregory C., Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory, Steg, Philippe Gabriel, Weitz, Jeffrey I., Suh, Eunyoung, Lu, Wentao, Barnathan, Elliot S., Raskob, Gary E., Spyropoulos, Alex C.
Publicado 2021

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

por Giannis, Dimitrios, Allen, Steven L., Tsang, James, Flint, Sarah, Pinhasov, Tamir, Williams, Stephanie, Tan, Gary, Thakur, Richa, Leung, Christian, Snyder, Matthew, Bhatia, Chirag, Garrett, David, Cotte, Christina, Isaacs, Shelby, Gugerty, Emma, Davidson, Anne, Marder, Galina S., Schnitzer, Austin, Goldberg, Bradley, McGinn, Thomas, Davidson, Karina W., Barish, Matthew A., Qiu, Michael, Zhang, Meng, Goldin, Mark, Matsagkas, Miltiadis, Arnaoutoglou, Eleni, Spyropoulos, Alex C.
Publicado 2021